论文部分内容阅读
目的探讨丙型肝炎患者的治疗及预后。方法对收治的８７例患者进行多因素分析。结果总有效率为６６．６７％，无应答和恶化占３３．３３％。有明确血清暴露史的预后较好，可能与病史明确，病程较短有关。并发其它慢性疾病者疗效较差，与机体既往健康状况有关。干扰素治疗有效，且与疗程呈正相关。结论建议有输血等血清暴露史者，应定期检测血清ＨＣＶ标志物，以便及时发现ＨＣＶ感染，早期使用干扰素，效果较好。
Objective To investigate the treatment and prognosis of hepatitis C patients. Methods 87 patients admitted to carry out multivariate analysis. Results The total effective rate was 66.67%, non-response and deterioration accounted for 33.33%. The prognosis of a clear history of serum exposure is better, may be related to a clear history, shorter duration. Concurrent with other chronic diseases, poor efficacy, and the body’s past health status. Interferon therapy is effective, and with the course of treatment was positively correlated. Conclusion It is suggested that there should be serum HCV markers such as blood transfusion. Serum HCV markers should be detected periodically so that HCV infection can be detected in time. Interferon is used early, and the effect is better.